About Us Services Careers FAQ Contact Us 0
Home Medical Devices Aerosol Delivery Devices Market Growth, Trends and Forecast to 2031
Aerosol Delivery Devices Market

Aerosol Delivery Devices Market Size, Share & Trends Analysis Report By Product (Dry powder inhalers, Metered dose inhalers, Nebulizers), By Application (Asthma, Chronic obstructive pulmonary disease, Cystic fibrosis, Non respiratory diseases), By Distribution Channel (Retail pharmacies, Hospital pharmacies, E-commerce) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD54313DR
Last Updated : May 11, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Aerosol Delivery Devices Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Dry powder inhalers
        1. By Value
      3. Metered dose inhalers
        1. By Value
      4. Nebulizers
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Asthma
        1. By Value
      3. Chronic obstructive pulmonary disease
        1. By Value
      4. Cystic fibrosis
        1. By Value
      5. Non respiratory diseases
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail pharmacies
        1. By Value
      3. Hospital pharmacies
        1. By Value
      4. E-commerce
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Dry powder inhalers
        1. By Value
      3. Metered dose inhalers
        1. By Value
      4. Nebulizers
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Asthma
        1. By Value
      3. Chronic obstructive pulmonary disease
        1. By Value
      4. Cystic fibrosis
        1. By Value
      5. Non respiratory diseases
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail pharmacies
        1. By Value
      3. Hospital pharmacies
        1. By Value
      4. E-commerce
        1. By Value
    5. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Dry powder inhalers
          1. By Value
        3. Metered dose inhalers
          1. By Value
        4. Nebulizers
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Asthma
          1. By Value
        3. Chronic obstructive pulmonary disease
          1. By Value
        4. Cystic fibrosis
          1. By Value
        5. Non respiratory diseases
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail pharmacies
          1. By Value
        3. Hospital pharmacies
          1. By Value
        4. E-commerce
          1. By Value
    6. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Dry powder inhalers
        1. By Value
      3. Metered dose inhalers
        1. By Value
      4. Nebulizers
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Asthma
        1. By Value
      3. Chronic obstructive pulmonary disease
        1. By Value
      4. Cystic fibrosis
        1. By Value
      5. Non respiratory diseases
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail pharmacies
        1. By Value
      3. Hospital pharmacies
        1. By Value
      4. E-commerce
        1. By Value
    5. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Dry powder inhalers
          1. By Value
        3. Metered dose inhalers
          1. By Value
        4. Nebulizers
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Asthma
          1. By Value
        3. Chronic obstructive pulmonary disease
          1. By Value
        4. Cystic fibrosis
          1. By Value
        5. Non respiratory diseases
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail pharmacies
          1. By Value
        3. Hospital pharmacies
          1. By Value
        4. E-commerce
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Dry powder inhalers
        1. By Value
      3. Metered dose inhalers
        1. By Value
      4. Nebulizers
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Asthma
        1. By Value
      3. Chronic obstructive pulmonary disease
        1. By Value
      4. Cystic fibrosis
        1. By Value
      5. Non respiratory diseases
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail pharmacies
        1. By Value
      3. Hospital pharmacies
        1. By Value
      4. E-commerce
        1. By Value
    5. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Dry powder inhalers
          1. By Value
        3. Metered dose inhalers
          1. By Value
        4. Nebulizers
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Asthma
          1. By Value
        3. Chronic obstructive pulmonary disease
          1. By Value
        4. Cystic fibrosis
          1. By Value
        5. Non respiratory diseases
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail pharmacies
          1. By Value
        3. Hospital pharmacies
          1. By Value
        4. E-commerce
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Dry powder inhalers
        1. By Value
      3. Metered dose inhalers
        1. By Value
      4. Nebulizers
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Asthma
        1. By Value
      3. Chronic obstructive pulmonary disease
        1. By Value
      4. Cystic fibrosis
        1. By Value
      5. Non respiratory diseases
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail pharmacies
        1. By Value
      3. Hospital pharmacies
        1. By Value
      4. E-commerce
        1. By Value
    5. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Dry powder inhalers
          1. By Value
        3. Metered dose inhalers
          1. By Value
        4. Nebulizers
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Asthma
          1. By Value
        3. Chronic obstructive pulmonary disease
          1. By Value
        4. Cystic fibrosis
          1. By Value
        5. Non respiratory diseases
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail pharmacies
          1. By Value
        3. Hospital pharmacies
          1. By Value
        4. E-commerce
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Dry powder inhalers
        1. By Value
      3. Metered dose inhalers
        1. By Value
      4. Nebulizers
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Asthma
        1. By Value
      3. Chronic obstructive pulmonary disease
        1. By Value
      4. Cystic fibrosis
        1. By Value
      5. Non respiratory diseases
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail pharmacies
        1. By Value
      3. Hospital pharmacies
        1. By Value
      4. E-commerce
        1. By Value
    5. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Dry powder inhalers
          1. By Value
        3. Metered dose inhalers
          1. By Value
        4. Nebulizers
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Asthma
          1. By Value
        3. Chronic obstructive pulmonary disease
          1. By Value
        4. Cystic fibrosis
          1. By Value
        5. Non respiratory diseases
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail pharmacies
          1. By Value
        3. Hospital pharmacies
          1. By Value
        4. E-commerce
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Aerosol Delivery Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. players are 3M Company
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Aerogen
    3. GlaxoSmithKline plc
    4. Johnson & Johnson
    5. Vectura Group plc
    6. Koninklijke Philips N.V.
    7. Merck & Co. Inc.
    8. Metall Zug AG
    9. Recipharm AB
    10. Teva Pharmaceutical Industries Ltd.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global implantable drug delivery devices industry market size was valued at USD 8,731.80 million in 2022. It is projected to reach USD 17,896.16 million by 2031, growing at a CAGR of 8.30% during the forecast period (2023-2031).  Implantabl
Buy Now
Global Report
Market OverviewThe global meal kit delivery services market size was worth USD 21.87 billion in 2023 and is expected to reach USD 68.54 billion by 2032, growing at a CAGR of 17.92% over the forecast period. (2023–2032) A meal kit
Buy Now
Global Report
Online Food Delivery Services Market Size The global online food delivery services market size was valued at t USD 84.33 billion in 2024 and is projected to reach from USD 99.33 billion in 2025 to USD 388.56 b
Buy Now
Global Report
Personal Mobility Devices Market Size The global personal mobility devices market size was valued at USD 9,929 million in 2021, presumed to reach USD 17,577 million in 2030, expanding at a CAGR of 7.4% during the forecast period.  Personal mob
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.